OptimizeRx (OPRX) Cash from Operations (2010 - 2026)

OptimizeRx has disclosed Cash from Operations across 17 years of filings, most recently posting $8.6 million for Q2 2026.

• In Q2 2026, Cash from Operations rose 88.8% year-over-year to $8.6 million; the TTM figure through Jun 2026 stood at $18.4 million (up 77.01% YoY), while the FY2025 annual figure was $18.7 million, up 282.8% from the prior year.
• Cash from Operations came in at $8.6 million for Q2 2026 at OptimizeRx, up from -$467000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of $8.6 million in Q2 2026 to a low of -$6.3 million in Q4 2023.
• Average Cash from Operations over 5 years is $2.0 million, with a median of $2.0 million recorded in 2024.
• Year-over-year, Cash from Operations sank 868.84% in 2023 and soared 3479.8% in 2025.
• Over 5 years, Cash from Operations stood at $2.8 million in 2022, then tumbled by 323.22% to -$6.3 million in 2023, then jumped by 103.16% to $198000.0 in 2024, then soared by 3479.8% to $7.1 million in 2025, then increased by 21.49% to $8.6 million in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were $8.6 million in Q2 2026, -$467000.0 in Q1 2026, and $7.1 million in Q4 2025.